← Leaderboards
Rebecca J Chan
Indiana Univ-Purdue Univ At Indianapolis
$3,008,970
Attributed
$3,971,368
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $378.8K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,971,368 · 8
By mechanism
R01$3,034,651 · 2
R21$593,900 · 2
T35$174,489 · 1
F32$144,328 · 1
R13$24,000 · 2
Top collaborators
- Reuben Kapur5 shared
- Janice S Blum1 shared
- Mignon Lee-Cheun Loh1 shared
- Sandra Holley Thomas1 shared
- Feng-Chun Yang1 shared
- Mervin C. Yoder1 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Edward F Srour$12,800,260
- Fredrick M Pavalko$5,060,595
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaBaseProtein Tyrosine PhosphataseMutationPtpn11 GeneCellsMyeloproliferative DiseaseHematopoieticMyelogenousScientistIn VivoHematopoietic Stem CellsJuvenile Myelomonocytic LeukemiaHypersensitivitySamplingGranulocyte-Macrophage Colony-Stimulating FactorIn VitroMutantMolecularBone MarrowInnovationGenesClinical TrialsGenetic
Grant awards (20)
Short-Term Training Program In Biomedical Sciences$174,489
T35 · FY2016 · HL · contact PI
HSC-Independent Mechanisms Underlying JMML$169,650
R21 · FY2016 · CA · contact PI
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)$10,000
R13 · FY2016 · CA · contact PI
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis$319,550
R01 · FY2015 · CA · contact PI
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)$4,000
R13 · FY2015 · CA · contact PI
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis$309,964
R01 · FY2014 · CA · contact PI
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)$5,000
R13 · FY2014 · CA
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis$300,377
R01 · FY2013 · CA · contact PI
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis$319,550
R01 · FY2012 · CA · contact PI
Midwest Blood Club Symposium, 2012$5,000
R13 · FY2012 · HL · contact PI
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis$319,550
R01 · FY2011 · CA · contact PI
Aberrant Monocytic Differentiation Induced by Gain-of-Function Shp2 Mutants$231,380
R21 · FY2010 · HL · contact PI
Aberrant Monocytic Differentiation Induced by Gain-of-Function Shp2 Mutants$192,870
R21 · FY2009 · HL · contact PI
Activating PTPN11 and c-kit Mutations in Myeloproliferative Disorder$357,938
R01 · FY2008 · HL · contact PI
Activating PTPN11 and c-kit Mutations in Myeloproliferative Disorder$359,123
R01 · FY2007 · HL · contact PI
Activating PTPN11 and c-kit Mutations in Myeloprolifera*$369,849
R01 · FY2006 · HL · contact PI
Activating PTPN11 and c-kit Mutations in Myeloprolifera*$378,750
R01 · FY2005 · HL
MOLECULAR MECHANISMS OF HEMATOPOIESIS AND LEUKEMIA$54,352
F32 · FY2002 · CA
MOLECULAR MECHANISMS OF HEMATOPOIESIS AND LEUKEMIA$47,348
F32 · FY2001 · CA
MOLECULAR MECHANISMS OF HEMATOPOIESIS AND LEUKEMIA$42,628
F32 · FY2000 · CA